Jacobson Allan Steven

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
11
Insider Sells Sum
$5.91M

Insider Activity of Jacobson Allan Steven

According to the SEC Form 4 filings, Jacobson Allan Steven, being in a position of

  1. director at PTC Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1230 shares for $63,370,
    over all time since 2014-03-18, has bought 0 shares, and sold 110462 shares for $5.91M.

The largest sale of all time was on 2023-05-11 and amounted to 23000 shares of PTC Therapeutics, Inc. for $1.27M.

Biography of Jacobson Allan Steven

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $63,3701100

Comparison of Insiders on Amount of Buys and Sells

2025-03-04SalePTC Therapeutics, Inc.
PTCT
director
1,230
0.0015%
$51.52$63,370+1.69%
2024-01-22SalePTC Therapeutics, Inc.
PTCT
director
10,000
0.0133%
$27.38$273,804+24.79%
2023-05-11SalePTC Therapeutics, Inc.
PTCT
director
23,000
0.0314%
$55.08$1.27M-48.01%
2020-11-04SalePTC Therapeutics, Inc.
PTCT
director
20,000
0.0293%
$60.00$1.2M-27.03%
2020-10-16SalePTC Therapeutics, Inc.
PTCT
director
5,000
0.0074%
$51.29$256,450-8.93%
2020-04-20SalePTC Therapeutics, Inc.
PTCT
director
17,900
0.0273%
$51.04$913,558+1.69%
2020-04-17SalePTC Therapeutics, Inc.
PTCT
director
2,100
0.0032%
$50.16$105,332+5.16%
2015-06-18SalePTC Therapeutics, Inc.
PTCT
director
5,000
0.0151%
$50.13$250,650-44.32%
2015-03-18SalePTC Therapeutics, Inc.
PTCT
director
16,616
0.0534%
$76.00$1.26M-50.76%
2014-09-18SalePTC Therapeutics, Inc.
PTCT
director
2,000
0.0068%
$40.16$80,320+29.15%
2014-03-18SalePTC Therapeutics, Inc.
PTCT
director
7,616
0.0305%
$31.18$237,499+13.07%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.